background

Filter By Category

Active Pharma Ingredients
Disease Dictionary

Archives

Posted by -

Active Pharma Ingredients / 27 Sep 2026

DAVALINTIDE

Generic Name: DAVALINTIDE

ABSTRACT -

Davalintide is an investigational peptide amylin analog with metabolic effects studied in obesity and diabetes. A peptide schematic is shown because this is not appropriately represented by a simple small-molecule bond-line structure.

DOSAGE -

No approved standard dosage has been established; administration in studies was protocol-specific.

SIDE EEFECTS -

  • Injection-site reactions
  • Nausea
  • Vomiting or abdominal discomfort
  • Headache
  • Fatigue

ALLERGIC REACTIONS -

  • (These symptoms may indicate an allergic reaction and require medical attention.)
  • Rash or hives
  • Swelling at or beyond the injection site
  • Shortness of breath
  • Anaphylaxis

DRUG INTERACTIONS-

  • Consider additive effects with drugs acting on the same endocrine or receptor pathway
  • Monitor glucose or hormone-related therapies where applicable
  • Review concomitant medicines that may worsen gastrointestinal effects

PREAUTONS–

  • Use proper administration technique
  • Monitor clinical response and tolerability
  • Dose adjustment or avoidance may be needed in special populations depending on the product

WARNINGS –

  • Use only as directed by a healthcare professional
  • Severe hypersensitivity is possible
  • Product-specific contraindications should be reviewed before use

Have any questions? or Need help Contact us – 022 6163 6163 | support@medicus.com

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2026 Copyright. All rights reserved. Powered by . Developed by Hats-Off

Log in with your credentials

Forgot your details?

Feedback